Oncosil appoints new CFO and Company Secretary

Company News

Oncosil Medical Limited (ASX:OSL) has announced the appointment of Tom Milicevic as Chief Financial Officer and Company Secretary.
 
Mr Milicevic has specific financial expertise in medical device and biotech companies and his appointment represents a pivotal hire for the company as it transitions from a development focus to the commercialisation of its Oncosil radiation treatment for cancer. 
 
Prior to joining Oncosil, Mr Milicevic was CEO and CFO of orthopedic medical device company, Allegra Orthopaedics International.
 
He also had a senior finance and accounting role with Cochlear. 
 
Oncosil Medical reported a net loss of $2.88 million at 30 June.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?